HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Konrad Feichtinger Selected Research

APD791

6/2010Discovery and structure-activity relationship of 3-methoxy-N-(3-(1-methyl-1H-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide (APD791): a highly selective 5-hydroxytryptamine2A receptor inverse agonist for the treatment of arterial thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Konrad Feichtinger Research Topics

Disease

2Sleep Initiation and Maintenance Disorders (Insomnia)
03/2012 - 08/2010
1Thrombosis (Thrombus)
06/2010

Drug/Important Bio-Agent (IBA)

35-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
03/2012 - 06/2010
2Serotonin (5 Hydroxytryptamine)IBA
08/2010 - 06/2010
1AmidesIBA
08/2010
1APD791IBA
06/2010